glp 1 osteoporosis glp-1 and GLP-1s and Bone Health: What the Evidence Says About Semaglutide, Bone Density, and Muscle Loss Do GLP-1 Drugs Cause Bone

Wojcikowski K, Stevenson L, Leach D, Wohlmuth H, Gobe G

A novel bloodbased biomarker for detection of autism spectrum disorders

If you have a background of specific health conditions, such as pancreatic inflammation, diabetic retinopathy, thyroid tumors, multiple endocrine neoplasia type 2, Type 1 diabetes, diabetic ketoacidosis, or kidney or liver disease, Ozempic may not be recommended for you

Both add important information to ongoing melanocortin receptor and synthetic peptide research

Beyond metabolic regulation, peptides also modulate the immune system, impacting the development of chronic inflammatory diseases

Fifth, cost-effectiveness analyses are critical given the high price of current GLP-1 RAs and the large potential treatment population: preliminary health-economic models suggest acceptable cost-effectiveness ratios in high-fibrosis patients with comorbid type 2 diabetes and cardiovascular disease, but robust data in broader MASLD populations are lacking